All sponsors

Sinotau Pharmaceutical Group

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING5
READOUTS ≤12 MONTHS3
Open Sinotau Pharmaceutical Group on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
XTR006
NCT07115238
P3RecruitingAlzheimer Disease; Neurofibrillary Tangle3542025-12-31
STB-XTR-003
NCT07443696
P2RecruitingIschemic Cardiomyopathy; Heart Failure402026-12-31
XTR004
NCT07439133
P3RecruitingCoronary Artery Disease(CAD)3952027-06
Lutetium[177Lu] Oxodotreotide Injection
NCT06398444
P2/3RecruitingAdvanced Neuroendocrine Neoplasm852027-06-01
Phase I:[177Lu]Lu-XT033 Injection
NCT06081686
P1/2RecruitingProstate Cancer322027-12-31 (+25 mo)